Literature DB >> 16945846

[Management strategies for the treatment of non malignant chronic pain in the elderly].

Serge Perrot1.   

Abstract

Chronic pain has a growing incidence with age. In the elderly, the most frequent etiologies of pain are musculoskeletal diseases, neuropathic pain and cancer. Pain management in older patients requires a comprehensive assessment, adapted to the patient's cognitive functioning, using specific tools, and taking into account the daily life activities and autonomy. Management includes drugs, especially paracetamol and level 2 and 3 opioids. Non steroidal anti-inflammatory drugs (NSAIDs) should be avoided, including COX-2 inhibitors. Drugs are to be prescribed regularly, pre-emptively, and via oral route. Immediate release drugs should be selected, and a slow increase of dosages. Local treatments should be preferred: local injections, topical application and physiotherapy. Rehabilitation, pool-therapy, crenotherapy may be proposed. In conclusion, chronic pain management in elderly patients does not importantly differ from that in younger patients. Specificities are more related to the assessment of pain and to the drugs side effects rather than to the type of drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945846

Source DB:  PubMed          Journal:  Psychol Neuropsychiatr Vieil        ISSN: 1760-1703


  2 in total

1.  The therapeutic management of chronic pain in ambulatory care patients aged 65 and over in France: the S.AGES Cohort. Baseline data.

Authors:  P Bertin; L Becquemont; E Corruble; G Derumeaux; B Falissard; O Hanon; M Pinget; F Forette
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

2.  Buprederm, a new transdermal delivery system of buprenorphine: pharmacokinetic, efficacy and skin irritancy studies.

Authors:  In Park; Dongwon Kim; Jindeog Song; Chang Hoon In; Seung-Wei Jeong; Sang Hun Lee; Bumchan Min; Dongho Lee; Sun-Ok Kim
Journal:  Pharm Res       Date:  2008-02-01       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.